Date Action Amount Person Type
Oct 05, 2022 Sell 5 600 Perry Mark L Stock Option (Right to Buy)
Oct 05, 2022 Sell 5 600 Patrick Deval L Stock Option (Right to Buy)
Oct 05, 2022 Sell 5 600 Morrison Scott W Stock Option (Right to Buy)
Oct 05, 2022 Sell 3 600 Thompson Alexis A. Restricted Stock Units
Oct 05, 2022 Sell 30 000 Yarno Wendy L Stock Option (Right to Buy)
Oct 05, 2022 Sell 7 500 Pizzo Philip A. Stock Option (Right to Buy)
Oct 05, 2022 Sell 5 600 Svoronos Dawn Stock Option (Right to Buy)
Oct 05, 2022 Sell 5 600 Pierce Glenn Stock Option (Right to Buy)
Oct 05, 2022 Sell 18 120 Smith-whitley Kim Restricted Stock Units
Oct 05, 2022 Sell 28 628 Johnson David Lee Stock Option (Right to Buy)
Oct 05, 2022 Sell 28 628 Choi Jung Stock Option (Right to Buy)
Oct 05, 2022 Sell 132 433 Love Ted W Stock Option (Right to Buy)
Oct 05, 2022 Sell 28 628 Habibizad Nazila Stock Option (Right to Buy)
Oct 05, 2022 Sell 26 454 Krehlik Carrie Restricted Stock Units
Oct 05, 2022 Sell 38 739 Farrow Jeffrey S Stock Option (Right to Buy)
Oct 05, 2022 Sell 28 628 Suvari Tricia Borga Stock Option (Right to Buy)
Oct 01, 2022 Buy 182 Habibizad Nazila Common Stock
Oct 01, 2022 Buy 1 375 Habibizad Nazila Common Stock
Oct 01, 2022 Sell 1 375 Habibizad Nazila Restricted Stock Units
Oct 01, 2022 Sell 182 Habibizad Nazila Restricted Stock Units
Sep 29, 2022 Sell 3 500 Habibizad Nazila Common Stock
Sep 29, 2022 Sell 73 855 Choi Jung Common Stock
Sep 28, 2022 Sell 22 000 Johnson David Lee Common Stock
Sep 27, 2022 Buy 23 653 Farrow Jeffrey S Common Stock
Sep 27, 2022 Sell 23 653 Farrow Jeffrey S Stock Option (Right to Buy)
Sep 27, 2022 Buy 83 Habibizad Nazila Common Stock
Sep 27, 2022 Buy 1 027 Habibizad Nazila Common Stock
Sep 27, 2022 Buy 2 043 Habibizad Nazila Common Stock
Sep 27, 2022 Buy 3 005 Habibizad Nazila Common Stock
Sep 27, 2022 Buy 23 597 Habibizad Nazila Common Stock
Sep 27, 2022 Sell 83 Habibizad Nazila Stock Option (Right to Buy)
Sep 27, 2022 Sell 3 005 Habibizad Nazila Stock Option (Right to Buy)
Sep 27, 2022 Sell 2 043 Habibizad Nazila Stock Option (Right to Buy)
Sep 27, 2022 Sell 1 027 Habibizad Nazila Stock Option (Right to Buy)
Sep 27, 2022 Sell 23 597 Habibizad Nazila Stock Option (Right to Buy)
Sep 27, 2022 Buy 18 291 Love Ted W Common Stock
Sep 27, 2022 Sell 18 291 Love Ted W Stock Option (Right to Buy)
Sep 27, 2022 Buy 2 674 Choi Jung Common Stock
Sep 27, 2022 Buy 2 674 Choi Jung Common Stock
Sep 27, 2022 Buy 74 964 Choi Jung Common Stock
Sep 27, 2022 Buy 2 275 Choi Jung Common Stock
Sep 27, 2022 Buy 16 902 Choi Jung Common Stock
Sep 27, 2022 Sell 2 275 Choi Jung Stock Option (Right to Buy)
Sep 27, 2022 Sell 16 902 Choi Jung Stock Option (Right to Buy)
Sep 27, 2022 Sell 2 674 Choi Jung Stock Option (Right to Buy)
Sep 27, 2022 Sell 74 964 Choi Jung Stock Option (Right to Buy)
Sep 13, 2022 Sell 35 300 Love Ted W Common Stock
Sep 13, 2022 Buy 17 650 Love Ted W Common Stock
Sep 09, 2022 Sell 221 200 Love Ted W Common Stock
Sep 01, 2022 Buy 2 208 Habibizad Nazila Common Stock
Sep 01, 2022 Sell 1 342 Habibizad Nazila Common Stock
Sep 01, 2022 Buy 414 Habibizad Nazila Common Stock
Sep 01, 2022 Buy 2 208 Johnson David Lee Common Stock
Sep 01, 2022 Sell 2 103 Johnson David Lee Common Stock
Sep 01, 2022 Buy 2 763 Johnson David Lee Common Stock
Sep 01, 2022 Buy 365 Johnson David Lee Common Stock
Sep 01, 2022 Sell 2 208 Johnson David Lee Restricted Stock Units
Sep 01, 2022 Sell 2 763 Johnson David Lee Restricted Stock Units
Sep 01, 2022 Buy 2 208 Smith-whitley Kim Common Stock
Sep 01, 2022 Sell 607 Smith-whitley Kim Common Stock
Sep 01, 2022 Buy 8 060 Krehlik Carrie Common Stock
Sep 01, 2022 Sell 3 552 Krehlik Carrie Common Stock
Sep 01, 2022 Buy 9 109 Love Ted W Common Stock
Sep 01, 2022 Buy 9 444 Love Ted W Common Stock
Sep 01, 2022 Sell 9 200 Love Ted W Common Stock
Sep 01, 2022 Sell 9 109 Love Ted W Restricted Stock Units
Sep 01, 2022 Sell 9 444 Love Ted W Restricted Stock Units
Sep 01, 2022 Sell 1 885 Farrow Jeffrey S Common Stock
Sep 01, 2022 Sell 2 208 Farrow Jeffrey S Restricted Stock Units
Sep 01, 2022 Sell 31 441 Farrow Jeffrey S Common Stock
Sep 01, 2022 Buy 2 208 Choi Jung Common Stock
Sep 01, 2022 Sell 1 861 Choi Jung Common Stock
Sep 01, 2022 Buy 2 763 Choi Jung Common Stock
Sep 01, 2022 Sell 2 208 Choi Jung Restricted Stock Units
Sep 01, 2022 Sell 2 763 Choi Jung Restricted Stock Units
Sep 01, 2022 Buy 2 208 Suvari Tricia Borga Common Stock
Sep 01, 2022 Sell 1 881 Suvari Tricia Borga Common Stock
Sep 01, 2022 Buy 2 763 Suvari Tricia Borga Common Stock
Sep 01, 2022 Buy 385 Suvari Tricia Borga Common Stock
Sep 01, 2022 Sell 2 208 Suvari Tricia Borga Restricted Stock Units
Sep 01, 2022 Sell 2 763 Suvari Tricia Borga Restricted Stock Units
Aug 18, 2022 Sell 4 678 Habibizad Nazila Common Stock
Aug 01, 2022 Buy 6 145 Suvari Tricia Borga Common Stock
Aug 01, 2022 Sell 2 126 Suvari Tricia Borga Common Stock
Aug 01, 2022 Sell 3 020 Suvari Tricia Borga Restricted Stock Units
Aug 01, 2022 Sell 3 125 Suvari Tricia Borga Restricted Stock Units
Aug 01, 2022 Buy 1 518 Habibizad Nazila Common Stock
Aug 01, 2022 Sell 526 Habibizad Nazila Common Stock
Aug 01, 2022 Buy 20 205 Love Ted W Common Stock
Aug 01, 2022 Sell 10 018 Love Ted W Common Stock
Aug 01, 2022 Sell 8 955 Love Ted W Restricted Stock Units
Aug 01, 2022 Sell 11 250 Love Ted W Restricted Stock Units
Aug 01, 2022 Buy 6 145 Choi Jung Common Stock
Aug 01, 2022 Sell 2 126 Choi Jung Common Stock
Aug 01, 2022 Sell 3 020 Choi Jung Restricted Stock Units
Aug 01, 2022 Sell 3 125 Choi Jung Restricted Stock Units
Aug 01, 2022 Buy 6 770 Johnson David Lee Common Stock
Aug 01, 2022 Sell 2 342 Johnson David Lee Common Stock
Aug 01, 2022 Sell 3 645 Johnson David Lee Restricted Stock Units
Aug 01, 2022 Sell 3 125 Johnson David Lee Restricted Stock Units
INSIDER POWER
-16.738
Last 100 transactions
Buy: 278 284 | Sell: 1 075 911 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -16.738.

In total, the insiders bought 278 284 and sold 1 075 911 GBT shares in the last 100 trades.

Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT